Atlal Abusanad

Dr. Atlal Abusanad


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2016 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
ADAshraf Dallol
Ashraf Dallol
ABAbdelbaset Buhmeida
Abdelbaset Buhmeida
MAMahmoud Shaheen Al-Ahwal
Mahmoud Shaheen Al-Ahwal
JAJAUDAH AL-MAGHRABI
JAUDAH AL-MAGHRABI
OBOsama Bajouh
Osama Bajouh
AAAdel M. Abuzenadah
Adel M. Abuzenadah
Colorectal cancer (CRC) is a heterogeneous disease with different molecular characteristics associated with many variables such as the sites from which the tumors originate or the presence or absence of chromosomal instability. Identification of such variables, particularly mutational hotspots, often carries a significant diagnostic and/or prognostic value that could ultimately affect the therapeutic outcome. High-throughput mutational analysis of 99 CRC formalin-fixed and paraffin-embedded (FFPE) cases was performed using the Cancer Hotspots Panel (CHP) v2 on the Ion Torrent™ platform. Correlation with survival and other Clinicopathological parameters was performed using Fisher’s exact test and Kaplan–Meier curve analysis. Targeted sequencing lead to the identification of frequent mutations in TP53 (65 %), APC (36 %), KRAS (35 %), PIK3CA (19 %), PTEN (13 %), EGFR (11 %), SMAD4 (11 %), and FBXW7 (7 %). Other genes harbored mutations at lower frequency. EGFR mutations were relatively frequent and significantly associated with young age of onset (p = 0.028). Additionally, EGFR or PIK3CA mutations were a marker for poor disease-specific survival in our cohort (p = 0.009 and p = 0.032, respectively). Interestingly, KRAS or PIK3CA mutations were significantly associated with poor disease-specific survival in cases with wild-type TP53 (p = 0.001 and p = 0.02, respectively). Frequent EGFR mutations in this cohort as well as the differential prognostic potential of KRAS and PIK3CA in the presence or absence of detectable TP53 mutations may serve as novel prognostic tools for CRC in patients from the Kingdom of Saudi Arabia. Such findings could help in the clinical decision-making regarding therapeutic intervention for individual patients and provide better diagnosis or prognosis in this locality.

20 July 2016 in BMC Genomics
Verified
Journal Article
Open access
JSJerry W. Shay
Jerry W. Shay
NHNoriko Homma
Noriko Homma
RZRuyun Zhou
Ruyun Zhou
MNMuhammad Imran Naseer
Muhammad Imran Naseer
ACAdeel Chaudhary
Adeel Chaudhary
SBSaleh Binsaleh
Saleh Binsaleh
O1 Regulation of genes by telomere length over long distances

11 January 2021 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
AAAtlal Abusanad
Atlal Abusanad
ABAssia Bensalem
Assia Bensalem
ESEmad Shash
Emad Shash
LMLayth Mula‐Hussain
Layth Mula‐Hussain
ZBZineb Benbrahim
Zineb Benbrahim
AJAbdul Rahman Jazieh
Abdul Rahman Jazieh

30 March 2022 in JCO Global Oncology
Verified
Journal Article
Open access
LMLayth Mula-Hussain
Layth Mula-Hussain
HMHala Mahdi
Hala Mahdi
ZRZhian Salah Ramzi
Zhian Salah Ramzi
MTMarwan Abdelwadod Tolba
Marwan Abdelwadod Tolba
MZMohamed Saad Zaghloul
Mohamed Saad Zaghloul
AJAbdul Rahman Jazieh
Abdul Rahman Jazieh
PURPOSE: Cancer is a leading cause of increased morbidity and mortality worldwide. This work aims to study the Arab world males' cancers (AMCs) and the similarities and disparities with the world males' cancers (WMCs) from different burden points of view. MATERIALS AND METHODS: A descriptive review of the 2020 Global Cancer Observatory revealed AMCs compared with the 2020 WMCs and the 2018 AMCs. Data on the top 27 AMCs were compared among the region's countries and the world groups. RESULTS: In 2020, a total estimate of 217,203 new AMCs, 2.2% of WMCs, with an average age-standardized rate of 133.5/100,000 population, compared with 222/100,000 population of WMCs, was observed. Death estimates were 148,395, 2.7% of WMCs, with an average age-standardized rate of 95/100,000 population, compared with 120.8/100,000 population of WMCs. The five-year prevalence was observed in 442,014, 1.8% of WMCs. The average AMC mortality to incidence ratio (MIR) was 0.68, compared with 0.55 in WMCs and 0.54 in Arab females. Lung cancer was the top in incidence and mortality, whereas penile cancer was the lowest. The range of MIRs among the 27 cancer types was 0.19-0.96. CONCLUSION: The descriptive review of the 2020 males' cancers in the Arab world revealed a relatively high MIR, compared with males' cancers worldwide and the females' cancers in the Arab world. This requires further evaluation to discern the underlying causes and address them systematically. More cancer control actions are warranted.

1 February 2022 in Global Journal on Quality and Safety in Healthcare
Verified
Journal Article
Open access
PDF file
AAAtlal Abusanad
Atlal Abusanad
In 1992, the Saudi Cancer Registry (SCR), a population-based registry, was established under the authority of the Ministry of Health (MOH). In 2014, the SCR was moved to the Saudi Health Council under the department of national registries in the National Center for Health Information. The SCR consists of the main office, which oversees data collection from all over the country through five regional offices to ensure full coverage of all healthcare facilities in the Kingdom. Cancer data are abstracted from patients' medical records based on clinical and/or histopathological diagnosis by SCR-trained cancer registrars.[1]Breast cancer is the most common malignancy among women in Saudi Arabia, with 2463 cases diagnosed between January and December of 2017. Breast cancer accounted for 17.7% of all cancers reported in Saudi citizens, and 30.9% of all cancers recorded among women of all ages.[2] SCR statistics for annual breast cancer incidence (BCI) and the percentage of each stage/year were analyzed to describe the impact of breast cancer screening on improving early-detection rates. Annual reports are available online where data from time points that corresponded to a milestone were extracted.[1] A total of 10,970 incident breast cancer cases spanning 17 years were included in the analysis; data were graphed and trends were compared. In the SCR, stages were constantly classified as localized, regional, distant, and unknown, described in its own manual (staging is the grouping of cancer cases into broad categories based on the extent of the disease staging according to the Surveillance, Epidemiology, and End Results [SEER] Summary Stage 2000).[3]The annual BCI increased by fivefold over 17 years (Fig. 1A). Until 2006–2007, there was a remarkably high percentage of regional stage, followed by a decrease in subsequent years, which was mirrored by a steady increase in localized stage. (Fig. 1B).The low percentage of early-stage disease in this review during the prescreening era (2001–2006) is likely because of delayed presentation and referral and lack of screening and awareness. Additionally, women aged 40 or older between 2001 to 2006 were born in the 1960s and preceding years when education and schooling for girls were limited, resulting in less self-care and health awareness.[4] In recent years, the incidence of localized stages has surpassed that of regional stages, and 2007–2008 marked the beginning of stage migration. (Fig. 1B). This considerable shift in stage distribution was caused by a change either in the staging system, which did not occur in this case, or an improvement in breast cancer awareness and screening programs. The breast cancer awareness–raising activity developed with the formation of the national breast cancer awareness program committee in 2003 as a non-profit initiative by the founder of the Zahra Breast Cancer Association, which was established later in 2007.[5] Several nongovernmental organizations have also founded breast screening programs in different regions of the Kingdom.[6] Interestingly, several pilot screening projects in different regions (Riyadh, Dammam, Jeddah, and Al-Qassim) were initiated as early as 1997.[7] All commonly reported low uptake rates and low cancer detection compared with western countries; however, follow-up periods were short, ranging from 2 to 5 years.[8] In 2012, the MoH initiated a nationwide Breast Cancer Early Detection (BCED) project to promote primary prevention through advertising awareness of modifiable risk factors associated with breast cancer, and secondary prevention through mammography for average-risk women who are > 40 years old.[9] Designated facilities, including mobile units across the Kingdom equipped with mammograms were made available and accessible free of charge for citizens. October is recognized nationally as the breast cancer awareness month, mirroring the international cancer calendar. Nonetheless, screening facilities are accessible throughout the year. Other nonprofit governmental and private initiatives for early detection of breast cancer are available, too. Altogether this has resulted in more detection of localized disease that matched with fewer cases of locally advanced disease. Plus, women who were 40 or older in recent years were born in the mid-1970s, when Saudi Arabia was undergoing major modernization and urbanization, which undoubtedly reflected on the population's social, educational, and health-awareness levels.[10]In addition to the overall incidence, the SCR reports cancer incidence by age group (Fig. 1C). Instead of using the mean or median age, categorical age groups are used: 15–29, 30–44, 45–59, 60–74, and 75+ years old. A sharp increase in BCI among the target age groups (i.e., the eligible age groups for screening) after the implementation of breast cancer screening should have been observed in comparison with the groups that are less likely to undergo screening (15–30 and 75+ years old) to confirm the potential effect of screening on the observed increased overall incidence. However, the lack of a clear differential BCI increase in the screening-eligible age groups neither confirms nor refutes the impact of screening on increasing BCI. Furthermore, the effect of screening might have been diluted owing to the summing of age groups creating an overlap of the cutoff age for the beginning of screening, as shown in the age group 30–44 (Fig. 1C). On the other hand, the parallel pattern of increase is highly suggestive of overall better health awareness, progress in seeking medical attention, and better accessibility to care even among elderly individuals. The caveat that SCR does not indicate the frequency of breast cancer stage incidence within each age group, which would have allowed for a more precise conclusion if documented. Although the ultimate goal of a breast cancer screening program is to reduce mortality, other...

22 March 2022 in Frontiers in Psychology
Verified
Journal Article
Open access
AAAtlal Abusanad
Atlal Abusanad
ABAssia Bensalem
Assia Bensalem
ESEmad Shash
Emad Shash
LMLayth Mula-Hussain
Layth Mula-Hussain
ZBZineb Benbrahim
Zineb Benbrahim
AJAbdul Rahman Jazieh
Abdul Rahman Jazieh
Background: Burnout (BO) is a recognized challenge among the oncology workforce. It affects both genders with a higher frequency among women. This study examined the factors contributing to the development of burnout among female oncologists from the Middle East and North Africa (MENA).Methods: An online cross-sectional survey was distributed to oncology professionals from different countries in the MENA region. The validated Maslach Burnout Inventory (MBI) of emotional exhaustion (EE), Depersonalization (DE), and Personal Achievement (PA) plus questions about demography/work-related factors and attitudes toward oncology were included. Data were analyzed to measure BO prevalence and related factors.Results: Between 10 February and 15 March 2020, 545 responses were submitted by female oncologists. The responses pre-dated the COVID-19 pandemic emergence in the region. BO prevalence was 71% among female professionals. Women aged <44 years represented 85% of the cohort. Sixty-two percent were married, 52% with children and one-third practiced a hobby. Two-thirds worked in medical oncology, worked for 25% on administrative work daily. Nearly half of the respondents (49%) expressed a recurring thought of quitting oncology and 70% had no burnout support or education. Inability to deliver optimal care was reported as distressing for career development in 82%. Factors significantly influencing the BO risk were identified. Marital status, having children, academia and years in practice did not impact the risk of BO among female oncologists from MENA.Conclusion: Female oncologists from the Middle East and North Africa (MENA) were found to have a high prevalence of BO. In this cohort, the majority of women oncology workers were young and in their early to mid-career stages. Burnout was linked to being younger, practicing in North African nations, having a heavy administrative load, and having persistent thoughts of quitting. Practicing a hobby and engaging in oncology communication, on the other hand, reduced the chance of BO. Burnout support and education, specifically for oncology women, is required.